Searching for just a few words should be enough to get started. If you need to make more complex queries, use the tips below to guide you.
Article type: Research Article
Authors: James, Anthony P. | Pal, Sebely | Gennat, Hanni C. | Vine, Donna F. | Mamo, John C.L.; *
Affiliations: Department of Nutrition, Dietetics and Food Science, Curtin University of Technology, Perth, Australia
Correspondence: [*] Corresponding author: Associate Professor John Mamo, Head, Department of Nutrition, Dietetics and Food Sciences, Curtin University of Technology, Hayman Road, Bentley, Western Australia 6102, OR, Box U1987, GPO Perth 6845, Australia. Tel.: +61 8 92667232; Fax: +61 8 92662958; E-mail: [email protected].
Abstract: The aggregation and deposition of amyloid-β (Aβ) in the brain is thought to be an early event in the pathology of Alzheimer's disease (AD). Many studies have reported the association of Aβ with lipoproteins from plasma suggesting an involvement of lipoprotein particles in Aβ transport. Chylomicron-like lipid emulsions, resembling chylomicrons in composition, size and metabolism were prepared in the presence of [125I]Aβ1-40. Aβ was found to associate significantly with these lipid emulsions during their preparation. The chylomicron-like emulsions containing Aβ were then injected into a lateral ear vein of conscious rabbits and blood sampled at regular intervals up to 30 mins. It was observed that there was no difference in the plasma clearance of [125I]Aβ and that of the 3H-cholesteryl ester, a marker of the emulsion particles, demonstrating that Aβ remains associated with these particles throughout both their lipolysis and tissue uptake. Our results show that Aβ can be metabolised in association with triglyceride rich lipoproteins (TRLs). In addition we report the presence of specific markers of TRLs of hepatic and intestinal origin in human CSF thus suggesting a potential means of cerebral Aβ delivery.
Keywords: Alzheimer's disease, lipid metabolism, apolipoproteins
DOI: 10.3233/JAD-2003-5302
Journal: Journal of Alzheimer's Disease, vol. 5, no. 3, pp. 179-188, 2003
IOS Press, Inc.
6751 Tepper Drive
Clifton, VA 20124
USA
Tel: +1 703 830 6300
Fax: +1 703 830 2300
[email protected]
For editorial issues, like the status of your submitted paper or proposals, write to [email protected]
IOS Press
Nieuwe Hemweg 6B
1013 BG Amsterdam
The Netherlands
Tel: +31 20 688 3355
Fax: +31 20 687 0091
[email protected]
For editorial issues, permissions, book requests, submissions and proceedings, contact the Amsterdam office [email protected]
Inspirees International (China Office)
Ciyunsi Beili 207(CapitaLand), Bld 1, 7-901
100025, Beijing
China
Free service line: 400 661 8717
Fax: +86 10 8446 7947
[email protected]
For editorial issues, like the status of your submitted paper or proposals, write to [email protected]
如果您在出版方面需要帮助或有任何建, 件至: [email protected]